BBIO — BridgeBio Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeLarge CapMomentum Trap

Annual balance sheet for BridgeBio Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	607	837	472	435	681
Net Total Accounts Receivable
Net Total Receivables	—	—	—	—	4.72
Prepaid Expenses
Total Other Current Assets
Total Current Assets	643	889	549	478	721
Net Property, Plant And Equipment	36.8	46	25.2	19.8	12.8
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	704	1,013	623	546	919
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	95.6	135	121	144	154
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	646	1,883	1,878	1,901	2,387
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	57.9	-870	-1,255	-1,354	-1,468
Total Liabilities & Shareholders' Equity	704	1,013	623	546	919
Total Common Shares Outstanding